Peer-reviewedLicence not statedMolecular Cell
TIRR inhibits the 53BP1-p53 complex to alter cell-fate programs
Related
- PFOS and GenX Induce Mitochondrial Toxicity and Differentially Alter Respiratory Complex Activities in Liver and Brain
- Co-targeting CDK2 and CDK9 inhibits MYC oncogenic programs and has anti-tumor effects in CIC-rearranged sarcoma
- Endogenous p53 inhibitor TIRR dissociates systemic metabolic health from oncogenic activity
- 53BP1 as a cofactor in the activation of the p53-family transcriptional program: A correlative multimodal microscopy approach
- TARBP2 facilitates renal cell carcinoma immune escape by suppressing 53BP1 phase separation to upregulate B7-H3.
BibTeX
@article{parnandi2026tirr,
title = {{TIRR inhibits the 53BP1-p53 complex to alter cell-fate programs}},
author = {Nishita Parnandi and Veronica Rendo and Gaofeng Cui and Maria Victoria Botuyan and Michaela Remisova and Huy Nguyen and Pascal Drané and Rameen Beroukhim and Matthias Altmeyer and Georges Mer and Dipanjan Chowdhury},
journal = {Molecular Cell},
year = {2026},
month = oct,
doi = {10.1016/j.molcel.2021.03.039},
url = {https://hal.science/hal-05829501v1},
}
RIS
TY - JOUR
TI - TIRR inhibits the 53BP1-p53 complex to alter cell-fate programs
AU - Nishita Parnandi
AU - Veronica Rendo
AU - Gaofeng Cui
AU - Maria Victoria Botuyan
AU - Michaela Remisova
AU - Huy Nguyen
AU - Pascal Drané
AU - Rameen Beroukhim
AU - Matthias Altmeyer
AU - Georges Mer
AU - Dipanjan Chowdhury
PY - 2026
DA - 2026/10/21
JO - Molecular Cell
DO - 10.1016/j.molcel.2021.03.039
UR - https://hal.science/hal-05829501v1
SN - 1097-2765
SN - 1097-4164
ER -